These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 25224629

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection.
    Veldkamp AI, van Heeswijk RP, Meenhorst PL, Mulder JW, Lange JM, Beijnen JH, Hoetelmans RM.
    J Chromatogr B Biomed Sci Appl; 1999 Oct 29; 734(1):55-61. PubMed ID: 10574190
    [Abstract] [Full Text] [Related]

  • 5. Development and validation of reversed-phase HPLC gradient method for the estimation of efavirenz in plasma.
    Gupta S, Kesarla R, Chotai N, Omri A.
    PLoS One; 2017 Oct 29; 12(5):e0174777. PubMed ID: 28505168
    [Abstract] [Full Text] [Related]

  • 6. Simple and rapid liquid chromatography method for determination of efavirenz in plasma.
    Ramachandran G, Kumar AK, Swaminathan S, Venkatesan P, Kumaraswami V, Greenblatt DJ.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May 01; 835(1-2):131-5. PubMed ID: 16574512
    [Abstract] [Full Text] [Related]

  • 7. Intra-individual variability in efavirenz plasma concentrations supports therapeutic drug monitoring based on quarterly sampling in the first year of therapy.
    Pereira SA, Branco T, Caixas U, Côrte-Real RM, Germano I, Lampreia F, Monteiro EC.
    Ther Drug Monit; 2008 Feb 01; 30(1):60-6. PubMed ID: 18223464
    [Abstract] [Full Text] [Related]

  • 8. High-performance liquid chromatographic method for the determination of HIV-1 non-nucleoside reverse transcriptase inhibitor efavirenz in plasma of patients during highly active antiretroviral therapy.
    Langmann P, Schirmer D, Väth T, Zilly M, Klinker H.
    J Chromatogr B Biomed Sci Appl; 2001 May 05; 755(1-2):151-6. PubMed ID: 11393699
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A sensitive and selective liquid chromatography/tandem mass spectrometry method for quantitative analysis of efavirenz in human plasma.
    Srivastava P, Moorthy GS, Gross R, Barrett JS.
    PLoS One; 2013 May 05; 8(6):e63305. PubMed ID: 23755102
    [Abstract] [Full Text] [Related]

  • 12. A validated method for quantification of efavirenz in dried blood spots using high-performance liquid chromatography-mass spectrometry.
    Amara AB, Else LJ, Tjia J, Olagunju A, Puls RL, Khoo S, Back DJ.
    Ther Drug Monit; 2015 Apr 05; 37(2):220-8. PubMed ID: 25162217
    [Abstract] [Full Text] [Related]

  • 13. Monitoring of HAART regime antiretrovirals in serum of acquired immunodeficiency syndrome patients by micellar liquid chromatography.
    Casas-Breva I, Peris-Vicente J, Rambla-Alegre M, Carda-Broch S, Esteve-Romero J.
    Analyst; 2012 Sep 21; 137(18):4327-34. PubMed ID: 22858583
    [Abstract] [Full Text] [Related]

  • 14. Variability of efavirenz plasma concentrations among pediatric HIV patients treated with efavirenz based combination antiretroviral therapy in Dar es Salaam, Tanzania.
    Sungi SS, Ngaimisi E, Ulenga N, Sasi P, Mugusi S.
    BMC Pharmacol Toxicol; 2018 Oct 23; 19(1):66. PubMed ID: 30352627
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Determination of efavirenz in human plasma by high-performance liquid chromatography with ultraviolet detection.
    Saras-Nacenta M, López-Púa Y, Lípez-Cortés LF, Mallolas J, Gatell JM, Carné X.
    J Chromatogr B Biomed Sci Appl; 2001 Nov 05; 763(1-2):53-9. PubMed ID: 11710583
    [Abstract] [Full Text] [Related]

  • 17. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction.
    Marzolini C, Telenti A, Buclin T, Biollaz J, Decosterd LA.
    J Chromatogr B Biomed Sci Appl; 2000 Mar 31; 740(1):43-58. PubMed ID: 10798293
    [Abstract] [Full Text] [Related]

  • 18. A fast and reliable reversed phase high performance liquid chromatography method for simultaneous determination of selected anti-retroviral and lumefantrine in human plasma.
    Maganda B, Heudi O, Cortinovis A, Picard F, Kretz O, Minzi O.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar 01; 919-920():52-60. PubMed ID: 23411019
    [Abstract] [Full Text] [Related]

  • 19. High-performance liquid chromatography method for analyzing the antiretroviral agent efavirenz in human plasma.
    Villani P, Pregnolato M, Banfo S, Rettani M, Burroni D, Seminari E, Maserati R, Regazzi MB.
    Ther Drug Monit; 1999 Jun 01; 21(3):346-50. PubMed ID: 10365651
    [Abstract] [Full Text] [Related]

  • 20. Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography.
    Notari S, Bocedi A, Ippolito G, Narciso P, Pucillo LP, Tossini G, Donnorso RP, Gasparrini F, Ascenzi P.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb 02; 831(1-2):258-66. PubMed ID: 16406832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.